Assessment of disease risk by quantitative determination of epimutation in normal tissues

Details for Australian Patent Application No. 2004281299 (hide)

International Classifications

Event Publications

18 May 2006 PCT application entered the National Phase

PCT publication WO2005/038047 Priority application(s): WO2005/038047

18 November 2010 Application Accepted

Published as AU-B-2004281299

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2E(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

13 January 2011 Section 223 Application Allowed

St Vincent's Hospital Sydney Limited; Victor Chang Cardiac Research Institute Limited The time in which to pay the examination response fee has been extended to 15 Dec 2010. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 38 MLC Centre Martin Place Sydney NSW 2000 2005

17 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.